What is this alert about? In April 2025, the drug company Novo Nordisk told the U.S. Food and Drug Administration (FDA) that fake versions of Ozempic (semaglutide) were found in the U.S. drug supply. Ozempic is a prescription medicine used to help adults with type 2 diabetes lower their blood sugar and reduce the risk of heart problems. It should only be taken under...
What Did the Research Discover? A systematic review and meta-analysis examined how well semaglutide helps people lose weight if they are obese or overweight but do not have diabetes. Researchers analyzed data from eight clinical trials with 4,567 participants, comparing semaglutide to a placebo. The results showed that semaglutide led to significant weight loss: On...
What Did the Research Discover? Scientists developed a new type of glucose sensor called a BioTFT (Biosensing Thin-Film Transistor) that can detect glucose in saliva instead of blood. This technology is non-invasive, meaning it does not require a blood sample, and it provides results in less than 60 seconds. The BioTFT sensor was created using a combination of two...
What Did the Research Discover? Menopausal vasomotor symptoms (VMS)—such as hot flashes and night sweats—are common experiences for many women during menopause. While previous research has established a link between obesity and the presence of menopausal symptoms, this study sought to explore whether the severity of these symptoms is also influenced by body weight...
What Did the Research Discover? Researchers investigated whether low-dose aspirin could reduce the risk of developing type 2 diabetes in older adults. The study included 16,209 people aged 70 and older (or 65 and older for some U.S. minority groups) who were generally healthy and did not have diabetes at the start of the study. Participants were randomly assigned to...
What did the research discover? This study examined how weight loss affects prediabetes and whether it can lead to remission, similar to type 2 diabetes. Researchers analyzed data from two large studies: the Prediabetes Lifestyle Intervention Study (PLIS) in Germany and the Diabetes Prevention Program (DPP) in the United States. Participants who lost at least 5% of...